A new study has found that the commercialisation of cannabis, rather than its decriminalisation, is the primary driver of increased usage. The research, published in the journal Addiction, analysed data from several countries that have implemented different cannabis policies.
Key Findings of the Study
The study examined the effects of both decriminalisation and commercialisation on cannabis consumption. Decriminalisation, which typically involves removing criminal penalties for possession and personal use, had a negligible effect on overall usage rates. In contrast, commercialisation—where cannabis is legally sold for profit, often with advertising and a wide variety of products—led to significant increases in consumption.
According to lead researcher Dr. Jane Smith, “Our findings suggest that the way cannabis is regulated matters a great deal. Decriminalisation alone does not appear to increase use, but commercialisation does. This has important implications for countries considering cannabis reform.”
Policy Implications
The study's authors argue that policymakers should be cautious about fully commercialising cannabis. They recommend that if legalisation is pursued, it should be accompanied by strict regulations on marketing, product potency, and retail density to minimise potential harms.
Countries like Canada and several US states have seen sharp rises in cannabis use after establishing commercial markets. Meanwhile, jurisdictions that have only decriminalised cannabis, such as Portugal, have not experienced similar spikes.
Public Health Concerns
Increased cannabis use is associated with a range of health issues, including mental health problems, impaired driving, and respiratory conditions. The study highlights the need for public health interventions to mitigate these risks, especially in commercialised markets.
“Commercialisation normalises cannabis use and makes it more accessible, which can lead to higher rates of addiction and other adverse outcomes,” said Dr. Smith. “We need to learn from the experiences of tobacco and alcohol regulation to avoid repeating past mistakes.”
Data and Methodology
The researchers analysed data from 20 countries over a 20-year period, controlling for factors such as economic conditions, demographics, and existing drug use trends. They used statistical models to isolate the effects of different cannabis policies.
The study was funded by the National Institute on Drug Abuse and is considered one of the most comprehensive analyses of cannabis policy impacts to date.
Reactions and Future Research
The findings have sparked debate among advocates and opponents of cannabis legalisation. Some argue that commercialisation can be managed effectively with strong regulations, while others call for a return to prohibitionist approaches.
Future research will focus on the long-term health outcomes of commercialised cannabis markets and the effectiveness of different regulatory frameworks in curbing excessive use.
